The Zaleplon Market is undergoing significant transformation as demand for effective sleep disorder therapies continues to rise globally. Zaleplon, a short-acting hypnotic agent commonly prescribed for sleep-onset insomnia, is gaining attention from clinicians and patients due to its rapid onset of action and reduced next-day residual effects. With increasing awareness of sleep health and a...